Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Necitumumab, a fully human IgG1 mAb directed against the EGFR for the potential treatment of cancer.

Necitumumab, a fully human IgG1 mAb directed against the EGFR for the potential treatment of cancer. Curr Opin Investig Drugs. 2010 Dec; 11(12):1434-41.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.